State Street Corp grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 5,700.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 213,561,844 shares of the biotechnology company’s stock after purchasing an additional 209,879,882 shares during the quarter. Axon Enterprise makes up approximately 2.4% of State Street Corp’s holdings, making the stock its 4th biggest holding. State Street Corp owned about 262.88% of Axon Enterprise worth $119,724,905,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Bouchey Financial Group Ltd. bought a new position in Axon Enterprise in the second quarter valued at approximately $215,000. The Manufacturers Life Insurance Company lifted its stake in shares of Axon Enterprise by 8,432.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. Barbara Oil Co. lifted its stake in shares of Axon Enterprise by 100.0% in the 2nd quarter. Barbara Oil Co. now owns 3,390 shares of the biotechnology company’s stock valued at $2,046,000 after purchasing an additional 1,695 shares during the period. Sequoia Financial Advisors LLC boosted its position in shares of Axon Enterprise by 1.4% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 4,443 shares of the biotechnology company’s stock worth $2,491,000 after purchasing an additional 63 shares during the last quarter. Finally, National Pension Service boosted its position in shares of Axon Enterprise by 18.4% in the 2nd quarter. National Pension Service now owns 118,234 shares of the biotechnology company’s stock worth $66,283,000 after purchasing an additional 18,398 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In related news, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 67,397 shares of company stock worth $38,160,884 over the last three months. 4.20% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on AXON
Axon Enterprise Stock Up 1.5%
Shares of AXON traded up $6.93 on Tuesday, hitting $458.99. The company’s stock had a trading volume of 246,271 shares, compared to its average volume of 1,053,399. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm’s fifty day moving average price is $545.60 and its 200-day moving average price is $485.63. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $792.16. The firm has a market capitalization of $37.29 billion, a price-to-earnings ratio of 190.41, a P/E/G ratio of 8.43 and a beta of 1.40.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same period last year, the company posted $2.12 EPS. The business’s quarterly revenue was up 35.3% on a year-over-year basis. On average, equities research analysts expect that Axon Enterprise, Inc will post 2.12 EPS for the current year.
About Axon Enterprise
Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.
The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.
Featured Articles
- Five stocks we like better than Axon Enterprise
- IonQ’s AI Breakthrough Looks Big—But Can It Drive Revenue?
- Broadcom CEO Holds $350B Outlook Strong Amid Calls to Slow Froniter AI Development
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
